BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 16376270)

  • 1. Pharmacotherapy of spasticity in children with cerebral palsy.
    Verrotti A; Greco R; Spalice A; Chiarelli F; Iannetti P
    Pediatr Neurol; 2006 Jan; 34(1):1-6. PubMed ID: 16376270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical treatment (non surgical) of spasticity in cerebral palsy].
    Calderón-González R; Calderón-Sepúlveda RF
    Rev Neurol; 2002 Jan 1-15; 34(1):1-6. PubMed ID: 11988886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Orally administered drugs in the treatment of spasticity].
    Campistol J
    Rev Neurol; 2003 Jul 1-15; 37(1):70-4. PubMed ID: 12861514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic interventions for reducing spasticity in cerebral palsy.
    Patel DR; Soyode O
    Indian J Pediatr; 2005 Oct; 72(10):869-72. PubMed ID: 16272661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy of spasticity in children with cerebral palsy.
    Chung CY; Chen CL; Wong AM
    J Formos Med Assoc; 2011 Apr; 110(4):215-22. PubMed ID: 21540003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.
    Dai AI; Wasay M; Awan S
    J Child Neurol; 2008 Dec; 23(12):1464-6. PubMed ID: 19073853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Management of spasticity in children with cerebral palsy].
    Matthews DJ; Balaban B
    Acta Orthop Traumatol Turc; 2009; 43(2):81-6. PubMed ID: 19448346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy.
    Crowner BE; Racette BA
    Pediatr Neurol; 2008 Oct; 39(4):253-8. PubMed ID: 18805363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Botulinum toxin type A in the treatment plan for cerebral palsy].
    Strobl W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():30-5. PubMed ID: 15506050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of childhood spasticity secondary to cerebral palsy using Botox.
    Gill C; Covington C; Padaliya B; Newman W; Pomeroy T; Charles PD
    Tenn Med; 2003 Nov; 96(11):511-3. PubMed ID: 14635360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin A in the management of focal muscle overactivity in children with cerebral palsy.
    Gibson N; Graham HK; Love S
    Disabil Rehabil; 2007 Dec; 29(23):1813-22. PubMed ID: 18033606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of botulinum toxin a in the management of lower limb spasticity in patients with cerebral palsy.
    Dursun N; Dursun E; Alican D
    Int J Clin Pract; 2002 Oct; 56(8):564-7. PubMed ID: 12425363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effect of botulinum toxin (A) in the management of calf spasticity in children with diplegic cerebral palsy.
    Hawamdeh ZM; Ibrahim AI; Al-Qudah AA
    Eura Medicophys; 2007 Sep; 43(3):311-8. PubMed ID: 17268388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type A for the treatment of the spastic equinus foot in cerebral palsy.
    Cardoso ES; Rodrigues BM; Barroso M; Menezes CJ; Lucena RS; Nora DB; Melo A
    Pediatr Neurol; 2006 Feb; 34(2):106-9. PubMed ID: 16458821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin and cerebral palsy: time for reflection?
    Gough M; Fairhurst C; Shortland AP
    Dev Med Child Neurol; 2005 Oct; 47(10):709-12. PubMed ID: 16174320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal Baclofen Infusion-Botulinum Toxin Combined Treatment Efficacy in the Management of Spasticity due to Cerebral Palsy.
    Marvulli R; Lagioia G; Ianieri G; Dell'Olio L; Zonno A; Riccardi M; Sinisi RB; Rizzo LB; Farì G; Megna M; Ranieri M
    CNS Neurol Disord Drug Targets; 2024; 23(7):917-926. PubMed ID: 38213169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy.
    Lundy CT; Doherty GM; Fairhurst CB
    Dev Med Child Neurol; 2009 Sep; 51(9):705-10. PubMed ID: 19459910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Medical treatment of spasticity].
    Rode G; Maupas E; Luaute J; Courtois-Jacquin S; Boisson D
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):247-55. PubMed ID: 12746699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: a randomized trial comparing two injection volumes.
    Hu GC; Chuang YC; Liu JP; Chien KL; Chen YM; Chen YF
    Clin Rehabil; 2009 Jan; 23(1):64-71. PubMed ID: 19114438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Botulinum toxin: a new dimension for spasticity].
    Reichel G
    MMW Fortschr Med; 2007 May; 149 Suppl 2():65-9. PubMed ID: 17724971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.